BDSX Valuation

Biodesix Inc

Add to Watchlist

Advanced Chart

0.446

+0.028(6.703%)1D

Overview
Forecast
Valuation
Earnings

BDSX Relative Valuation

BDSX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BDSX is overvalued; if below, it's undervalued.

Historical Valuation

Biodesix Inc (BDSX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.60 is considered Undervalued compared with the five-year average of -5.25. The fair price of Biodesix Inc (BDSX) is between 2.55 to 5.70 according to relative valuation methord. Compared to the current price of 0.43 USD , Biodesix Inc is Undervalued By 83%.

Relative Value

Fair Zone

2.55-5.70

Current Price：0.43

83%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

5.53

P/B

Median3y

-4.86

Median5y

0.23

-72.29

FCF Yield

Median3y

-43.58

Median5y

-35.06

Competitors Valuation Multiple

The average P/S ratio for BDSX's competitors is 13.89, providing a benchmark for relative valuation. Biodesix Inc Corp (BDSX) exhibits a P/S ratio of 0.71, which is -94.87% above the industry average. Given its robust revenue growth of 21.19%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap